$17.36
0.050.29%
At close: -
$17.36
0.000.00%
After Hours: 4:00 PM EDT
Neurogene reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Neurogene using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-18 | $-1.19 | $-1.22 | 2.46 % |
Q2 | 2024-08-09 | $-1.09 | $-1.05 | -3.81 % |
Q1 | 2024-05-10 | $-1.00 | $-1.13 | 11.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Neurogene (NGNE) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on November 18, 2024 for Q3.
The Actual EPS was $-1.19, which beat the estimate of $-1.22.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.